Connable Office Inc’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Connable Office Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Sell	31,114 -515	-2%	-$17.2K	0.09%	90
2026 Q1	$953K	Buy	+31,629	New	+$1.02M	0.09%	90
2017 Q1	–	Sell	-29,640	Closed	-$1.07M	–	207
2016 Q4	$1.07M	Hold	29,640	–	–	0.25%	80
2016 Q3	$1.36M	Buy	29,640 +22,230	+300%	+$1.16M	0.33%	72
2016 Q2	$372K	Buy	7,410 +415	+6%	+$22.1K	0.1%	98
2016 Q1	$374K	Buy	6,995 +1,235	+21%	+$72.5K	0.1%	96
2015 Q4	$378K	Sell	5,760 -4,918	-46%	-$304K	0.11%	104
2015 Q3	$603K	Sell	10,678 -2,568	-19%	-$167K	0.18%	79
2015 Q2	$783K	Hold	13,246	–	–	0.21%	69
2015 Q1	$825K	Buy	13,246 +855	+7%	+$49.7K	0.21%	69
2014 Q4	$713K	Sell	12,391 -107	-0.9%	-$5.96K	0.19%	73
2014 Q3	$672K	Buy	12,498 +875	+8%	+$46.4K	0.18%	75
2014 Q2	$609K	Buy	11,623 +7,595	+189%	+$388K	0.16%	79
2014 Q1	$213K	Buy	+4,028	New	+$186K	0.06%	198

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Connable Office Inc's TEVA Position: Q2 2026 in Review

Connable Office Inc reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 1.6% in Q2 2026, selling an estimated $17.2K and leaving 31,114 shares worth $1.05M. The position accounts for 0.09% of the portfolio, ranked #90.

Connable Office Inc first reported a position in TEVA in Q1 2014 and has held it in 14 quarters since. The position peaked at $1.36M in Q3 2016. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Connable Office Inc held 31,114 shares of Teva Pharmaceutical Industries Limited worth $1.05M as of Q2 2026.
Connable Office Inc sold 515 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $17.2K.
Teva Pharmaceutical Industries Limited made up 0.09% of Connable Office Inc's portfolio in Q2 2026, its #90 holding.
Connable Office Inc first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 14 quarters since.
Connable Office Inc's Teva Pharmaceutical Industries Limited position peaked at $1.36M in Q3 2016.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.